January 23, 2012 | Rickerson Felix, TGA Sciences, Inc.
TGA Sciences, Inc (“TGA”) and Sanguine BioSciences, Inc (“Sanguine”) have entered into a co-marketing agreement, in which Sanguine will market TGA’s Bioassay Development services in conjunction with its rapidly-expanding product offering, including PBMC and biospecimen from healthy and patient donors.
July 26, 2011
TGA Sciences, Inc. has received its certification from the European Medicines Agency (EMA). The CRO is currently FDA registered and inspected, the EMA certification will add to an already impressive list of registrations, licenses and accreditations currently held by TGA Sciences, Inc.
August 24, 2010
TGA Sciences, Inc. now offers The Endosafe PTS system, which allows for the analysis of multiple endotoxin samples at a time in as little as 15 minutes. Read more about our
Endotoxin Testing services.